National Vision Holdings Inc... Show more
an operator of retail locations offering eye exams, eyeglasses and contact lenses
Industry SpecialtyStores
A.I.dvisor indicates that over the last year, EYE has been loosely correlated with HNST. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if EYE jumps, then HNST could also see price increases.
| Ticker / NAME | Correlation To EYE | 1D Price Change % | ||
|---|---|---|---|---|
| EYE | 100% | N/A | ||
| HNST - EYE | 47% Loosely correlated | -1.54% | ||
| LOW - EYE | 43% Loosely correlated | -1.59% | ||
| CPRT - EYE | 43% Loosely correlated | +0.52% | ||
| WSM - EYE | 43% Loosely correlated | -0.88% | ||
| CWH - EYE | 42% Loosely correlated | -1.57% | ||
More | ||||
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EYE advanced for three days, in 203 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where EYE's RSI Oscillator exited the oversold zone, 25 of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 56 cases where EYE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for EYE just turned positive on September 17, 2026. Looking at past instances where EYE's MACD turned positive, the stock continued to rise in 31 of 44 cases over the following month. The odds of a continued upward trend are 70%.
EYE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EYE as a result. In 62 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for EYE entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.421) is normal, around the industry mean (1.755). P/E Ratio (26.008) is within average values for comparable stocks, (241.673). Projected Growth (PEG Ratio) (0.050) is also within normal values, averaging (1.113). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.657) is also within normal values, averaging (1.033).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. EYE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.